Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Koup

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Pediatrics|November 1, 1976
Theophylline pharmacokinetics in premature infants with apneaG Giacoia, W J Jusko, J Menke, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1978
High-performance liquid chromatographic assay of chloramphenicol in serumJ R Koup, B Brodsky, A Lau, et al.
Clinical Pharmacokinetics|November 1, 1979
Hypothesis for the individualisation of drug dosageJ R Koup, C M Sack, A L Smith, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1979
Chloramphenicol pharmacokinetics in hospitalized patientsJ R Koup, A H Lau, B Brodsky, et al.
Therapeutic Drug Monitoring|January 1, 1986
Pharmacokinetics of rifampin in children. I. Multiple dose intravenous infusionJ R Koup, J Williams-Warren, A Weber, et al.
Developmental Pharmacology and Therapeutics|January 1, 1980
Factors affecting theophylline pharmacokinetics in premature infants with apneaD M Hilligoss, W J Jusko, J R Koup, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1979
Relationship between serum and saliva chloramphenicol concentrationsJ R Koup, A H Lau, B Brodsky, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1975
Digoxin concentrations in serum and salivaW J Jusko, L Gerbracht, L H Golden, et al.
Clinical Pharmacokinetics|September 25, 1999
Clinical pharmacokinetics of troglitazoneC M Loi, M Young, E Randinitis, et al.
Clinical Pharmacology and Therapeutics|July 1, 1975
Digoxin pharmacokinetics: role of renal failure in dosage regimen designJ R Koup, W J Jusko, C M Elwood, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Pediatrics|November 1, 1976
Theophylline pharmacokinetics in premature infants with apneaG Giacoia, W J Jusko, J Menke, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1978
High-performance liquid chromatographic assay of chloramphenicol in serumJ R Koup, B Brodsky, A Lau, et al.
Clinical Pharmacokinetics|November 1, 1979
Hypothesis for the individualisation of drug dosageJ R Koup, C M Sack, A L Smith, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1979
Chloramphenicol pharmacokinetics in hospitalized patientsJ R Koup, A H Lau, B Brodsky, et al.
Therapeutic Drug Monitoring|January 1, 1986
Pharmacokinetics of rifampin in children. I. Multiple dose intravenous infusionJ R Koup, J Williams-Warren, A Weber, et al.
Developmental Pharmacology and Therapeutics|January 1, 1980
Factors affecting theophylline pharmacokinetics in premature infants with apneaD M Hilligoss, W J Jusko, J R Koup, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1979
Relationship between serum and saliva chloramphenicol concentrationsJ R Koup, A H Lau, B Brodsky, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1975
Digoxin concentrations in serum and salivaW J Jusko, L Gerbracht, L H Golden, et al.
Clinical Pharmacokinetics|September 25, 1999
Clinical pharmacokinetics of troglitazoneC M Loi, M Young, E Randinitis, et al.
Clinical Pharmacology and Therapeutics|July 1, 1975
Digoxin pharmacokinetics: role of renal failure in dosage regimen designJ R Koup, W J Jusko, C M Elwood, et al.
Pageof 10